Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Español Near me My list Help
US Patient GuideUSA
Surprise me
Prescription medicine

Coral snake (micrurus fulvius) immune globulin antivenin (equine)

Brand names: North American Coral Snake Antivenin (Equine)

Full FDA label All drugs

Official FDA data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the drug label, the NDC Directory, Drugs@FDA, recall reports and the drug shortage list. Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

At a glance

NoBoxed warning
None listedFDA shortage list
0Recalls (FDA reports)
1Companies

Quick answers

What is Coral snake (micrurus fulvius) immune globulin antivenin (equine) used for?
The FDA-approved label (North American Coral Snake Antivenin (Equine), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., November 22, 2022) says: “North American Coral Snake Antivenin (Equine) is indicated only for the treatment of envenomation caused by bites of North American coral snakes - Micrurus (including the eastern and Texas varieties). North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snakes - Micrurus.” This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.
Does Coral snake (micrurus fulvius) immune globulin antivenin (equine) have a boxed warning?
No. None of the 1 FDA labels we found for this medicine has a boxed warning.
Is there a shortage of Coral snake (micrurus fulvius) immune globulin antivenin (equine)?
No current shortage is listed by the FDA for the products of this medicine (FDA data from October 30, 2026).
Has Coral snake (micrurus fulvius) immune globulin antivenin (equine) been recalled?
No recall linked to the products of this medicine appears in the FDA enforcement reports we use.
Who makes Coral snake (micrurus fulvius) immune globulin antivenin (equine)?
1 company lists prescription products of Coral snake (micrurus fulvius) immune globulin antivenin (equine) in the FDA NDC Directory, including Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc..

What Coral snake (micrurus fulvius) immune globulin antivenin (equine) is used for

Quoted from the “Indications and Usage” section of the FDA-approved label.

North American Coral Snake Antivenin (Equine) is indicated only for the treatment of envenomation caused by bites of North American coral snakes - Micrurus (including the eastern and Texas varieties). North American Coral Snake Antivenin (Equine) is a horse-derived antivenin indicated for the treatment of envenomation caused by North American coral snakes - Micrurus.

— FDA label: North American Coral Snake Antivenin (Equine), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., effective November 22, 2022. Read the full label on DailyMed →

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or change any medicine.

Boxed warning

A boxed warning (“black box”) is the FDA’s strongest warning on a drug label, for serious or life-threatening risks.

The label quoted above has no boxed warning.

Forms and how it is given

Dosage formsInjection, powder, for solution
RouteIntravenous
Prescription products1 in the FDA NDC Directory
Brand namesNorth American Coral Snake Antivenin (Equine)

Companies that list this medicine

Labelers in the FDA NDC Directory: the company named on the package (maker or distributor), with the number of prescription products.

FDA approval history

  • BLA: Biologics License Application: how a biologic medicine (made from living cells) is approved.
Brand and biologic applications
ApplicationSponsorApprovedLater changes approved
BLA101099 —Date not on file —

Shortage status

The FDA drug shortage list does not show these products.

FDA Drug Shortages database →

Recalls

No recall linked to these products (by their NDC code) appears in the FDA enforcement reports.

Official identifiers

RxCUI (RxNorm)1858981
SPL set ID of the quoted label6d0f94b4-82ca-37c7-edb0-4f0702cf6c8d
FDA labels (SPL)1
FDA applicationsBLA101099
Active ingredients (FDA)CORAL SNAKE (MICRURUS FULVIUS) IMMUNE GLOBULIN ANTIVENIN (EQUINE)

Sources

  1. FDA-approved label on DailyMed (National Library of Medicine) — North American Coral Snake Antivenin (Equine), Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc., effective November 22, 2022; via openFDA, FDA data exported October 30, 2026, retrieved October 31, 2026
  2. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. Drug shortages (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026

openFDA data is provided by the FDA as is; it may be incomplete. Always rely on the label that comes with your medicine. FDA Enforcement Report search →

Report an error → · Information for medicine makers